Back to STATE STREET CORP STATE STREET CORP

TNXPTNXP
6 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in TONIX PHARMACEUTICALS HLDG C

STATE STREET CORP holds 271,374 shares of TNXP (TONIX PHARMACEUTICALS HLDG C), worth $3.5M as of 2026-Q2. The position was increased (+17.7% shares). TNXP represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$3.5M

Current Shares

271,374

Total Value Change

+$3.1M

Total Shares Change

+251,321

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
271,374
+17.7%
$3.5M0.0%$12.76
31
2026-Q1
Increased
230,607
+20.2%
$3.2M0.0%$13.94
31
2025-Q4
Increased
191,855
+25.8%
$3M0.0%$15.82
32
2025-Q3
Increased
152,544
+23.8%
$3.7M0.0%$24.76
32
2025-Q2
Increased
123,257
+514.7%
$4.4M0.0%$34.89
43
2025-Q1
New
20,053
-
$358,4470.0%$20.17
36

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used